CAM
RMD icon

Cresset Asset Management’s ResMed RMD Stock Holding History

Cresset Asset Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,106
Closed -$482K – 1840
2024
Q4 		$482K Sell
2,106
-12,440
-86% -$3M ﹤0.01% 1103
2024
Q3 		$3.55M Buy
14,546
+2,302
+19% +$514K 0.01% 560
2024
Q2 		$2.34M Buy
12,244
+3,492
+40% +$709K 0.01% 651
2024
Q1 		$1.73M Buy
8,752
+829
+10% +$152K 0.01% 717
2023
Q4 		$1.36M Buy
7,923
+2,920
+58% +$449K 0.01% 752
2023
Q3 		$740K Buy
5,003
+684
+16% +$124K ﹤0.01% 986
2023
Q2 		$944K Buy
+4,319
New +$963K ﹤0.01% 971
2022
Q4 		– Sell
-1,278
Closed -$278K – 861
2022
Q3 		$278K Sell
1,278
-49
-4% -$11.2K ﹤0.01% 694
2022
Q2 		$278K Sell
1,327
-894
-40% -$190K ﹤0.01% 734
2022
Q1 		$539K Sell
2,221
-656
-23% -$159K 0.01% 583
2021
Q4 		$749K Sell
2,877
-1,124
-28% -$292K 0.01% 547
2021
Q3 		$1.05M Buy
4,001
+397
+11% +$109K 0.01% 384
2021
Q2 		$888K Buy
3,604
+195
+6% +$41K 0.01% 390
2021
Q1 		$661K Buy
3,409
+261
+8% +$52.3K 0.01% 398
2020
Q4 		$669K Sell
3,148
-111
-3% -$22.1K 0.01% 328
2020
Q3 		$559K Buy
3,259
+61
+2% +$11.3K 0.01% 355
2020
Q2 		$614K Buy
3,198
+754
+31% +$123K 0.01% 303
2020
Q1 		$360K Buy
2,444
+304
+14% +$48.4K 0.01% 347
2019
Q4 		$332K Buy
2,140
+39
+2% +$5.62K 0.01% 397
2019
Q3 		$284K Buy
2,101
+36
+2% +$4.72K 0.01% 403
2019
Q2 		$252K Sell
2,065
-1,304
-39% -$144K 0.01% 377
2019
Q1 		$350K Buy
3,369
+1,332
+65% +$137K 0.01% 235
2018
Q4 		$232K Buy
+2,037
New +$218K 0.01% 189

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Cresset Asset Management's RMD Position: Q1 2025 in Review

Cresset Asset Management sold out of ResMed (RMD) in Q1 2025, closing a stake of 2,106 shares — an estimated $482K sold.

Cresset Asset Management first reported a position in RMD in Q4 2018 and held it in 23 quarters. The position peaked at $3.55M in Q3 2024. 885 funds tracked by Wall St. Rank hold RMD as of Q1 2025.

  • Cresset Asset Management reported no remaining ResMed position as of Q1 2025 after selling out during the quarter.
  • Cresset Asset Management sold 2,106 ResMed shares in Q1 2025, an estimated $482K.
  • Cresset Asset Management first reported a position in ResMed in Q4 2018 and held it in 23 quarters.
  • Cresset Asset Management's ResMed position peaked at $3.55M in Q3 2024.
  • 885 funds tracked by Wall St. Rank held ResMed as of Q1 2025.

Based on Cresset Asset Management's 13F filing for Q1 2025, filed 13 May 2025.